Biological E and GVK BIO announce strategic R&D partnership

India |  News | 0 Comment | 31 Jul, 2019

GVK BIO, a global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a rapidly growing pharmaceutical company that develops, manufactures and market...Read more

Strides enters into JV with Sihuan Pharma

India |  News | 0 Comment | 30 Jul, 2019

Indian firm Strides Pharma Science Limited has announced that its step down subsidiary Strides Pharma Global Pte, Singapore (SPG) has entered into a Joint Venture (JV) with Sun Moral Intern...Read more

Alvotech, Cipla Gulf to commercialise key biosimilar in few emerging markets

India |  News | 0 Comment | 29 Jul, 2019

Biopharmaceutical company Alvotech and Cipla Gulf FZ LLC, a wholly-owned subsidiary of the leading India headquartered pharmaceutical company Cipla Limited, have announced that Alvotech and...Read more

Dr. Reddy's announces launch of Ramelteon Tablets in the U.S. Market

India |  News | 0 Comment | 23 Jul, 2019

Dr. Reddy’s Laboratories Ltd. has announced the launch of Ramelteon Tablets, 8 mg, a therapeutically equivalent generic version of Rozerem® (ramelteon, 8 mg) Tablets, approve...Read more

Fossil Remedies to launch innovative franchise pharma platform

India |  News | 1 Comment | 18 Jul, 2019

Fossil Remedies, a manufacturer and marketer of pharmaceutical products in the healthcare industry in Ahmedabad, India, announced the implementation of their new PCD Pharma Franchise P...Read more

Hope for restoring sight in acid attack victims

India |  News | 0 Comment | 15 Jul, 2019

For the first time a tissue-softening enzyme, collagenase, will be used in patients who have suffered acid attacks or industrial accidents. It follows research by a team from Newcastle Uni...Read more

Takeda expands India portfolio of rare disease therapies

India |  News | 0 Comment | 15 Jul, 2019

Takeda has announced the launch of its Enzyme Replacement Therapy portfolio for Lysosomal Storage Disorders (LSD) in India in line with its commitment to address the unmet needs of patients...Read more

Glenmark & Torrent to co-market diabetic drug in India

India |  News | 0 Comment | 12 Jul, 2019

Glenmark Pharmaceuticals Ltd. (Glenmark), and Torrent Pharmaceuticals Limited (Torrent) have announced that they have entered into a non-exclusive sub-licensing agreement to co-market sodiu...Read more

Lupin launches Imatinib Mesylate tablets

India |  News | 0 Comment | 09 Jul, 2019

Pharma major Lupin Limited (Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg (base) and 400 mg (base). Lupin’s alliance partner Natco had received an approval from the...Read more

Glenmark receives ANDA approval for Ranolazine Extended-Release Tablets

India |  News | 0 Comment | 09 Jul, 2019

Glenmark Pharmaceuticals Inc. has been granted final approval by the United States Food & Drug Administration for Ranolazine Extended-Release Tablets, 500 mg and 1,000 mg, a generic ver...Read more

Accutest Biologics Private Limited (ABPL) wins OECD GLP certification

India |  News | 0 Comment | 09 Jul, 2019

Accutest Biologics Private Limited (ABPL), a leading India-based contract research company (SRC) dedicated to biochemical characterization and high-quality bioanalytical services that accom...Read more

Alembic Pharma gets USFDA nod for Clonazepam to treat seizures

India |  News | 0 Comment | 02 Jul, 2019

Alembic Pharmaceuticals Limited has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Clonazepam Orally Disintegrating Tab...Read more

World Bank provides $400M to eliminate TB in India

India |  News | 0 Comment | 01 Jul, 2019

The World Bank and the Government of India have signed a loan agreement of $400 million for the Program Towards Elimination of Tuberculosis (TB). The program aims to improve the coverage a...Read more

Glenmark receives ANDA approval for Ezetimibe and Simvastatin Tablets

India |  News | 0 Comment | 28 Jun, 2019

Glenmark Pharmaceuticals has been granted final approval by the USFDA for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, a generic version of Vyt...Read more

Sun Pharma enters into two agreements with China Medical System

India |  News | 0 Comment | 28 Jun, 2019

Indian firm Sun Pharmaceutical has announced that one of its wholly owned subsidiaries has entered into two exclusive licensing agreement with a subsidiary of China Medical System Holdings ...Read more

NATHEALTH & the Netherlands explore bilateral collaborations in Digital Health

India |  News | 0 Comment | 25 Jun, 2019

To create a platform that brings together the Dutch and Indian expertise in digital technologies, apex Healthcare industry body-NATHEALTH and the Netherlands Embassy recently organized a Di...Read more

Glenmark receives tentative ANDA approval for Clindamycin Phosphate Foam, 1%

India |  News | 0 Comment | 20 Jun, 2019

Glenmark Pharmaceuticals has been granted tentative approval by the United States Food & Drug Administration for Clindamycin Phosphate Foam, 1%, a generic version of EVOCLIN® Foam, ...Read more

Zydus’ Nesher Pharma gets final USFDA nod for Lovaza capsules

India |  News | 0 Comment | 17 Jun, 2019

Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the USFDA to market Omega-3-Acid Ethyl Esters Capsules USP (US RLD &ndash...Read more